“VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunization (AEFIs) – are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring (PIDM). WHO PIDM was created in 1968 to ensure the safer and more effective use of medicinal products…
Special note regarding COVID-19 vaccine data: To see VigiBase data on COVID-19 vaccines, search for “covid-19 vaccine”. Please note that VigiAccess, as a result of the terminology used to structure the information, will group the data for vaccines by disease (for example, “Measles vaccine”, “Mumps vaccine”). This means that even searches for exact tradenames, such as “Comirnaty” or “Covishield”, will result in the total number of cases reported for all COVID-19 vaccines. It is not possible in VigiAccess to separate the numbers for specific vaccines."
Notes:
- On February 6, 2022, a query of VigiAccess for ‘covid-19 vaccine’ (as explained above) produced the results below. The ‘Total number of records retrieved’ was 3,155,004, and the total for each type of adverse event is presented in parentheses. For comparison, the results of a query for ‘influenza vaccine’ are also provided, which show 281,365 ‘Total number of records retrieved’ for the years 1968-2022.
- On April 5, 2023, a query of VigiAccess for ‘covid-19 vaccine’ returned 4,962,301 reports.
VigiAccess was "launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase."
© Copyright World Health Organization (WHO), 2025. All Rights Reserved.
Copyright notice
https://www.who.int/about/policies/terms-of-use
The information in the various pages of the WHO web site is issued by the World Health Organization for general distribution. The information presented is protected under the Berne Convention for the Protection of Literature and Artistic works, under other international conventions and under national laws on copyright and neighbouring rights. Extracts of the information in the web site may be reviewed, reproduced or translated for research or private study but not for sale or for use in conjunction with commercial purposes.